161 related articles for article (PubMed ID: 22416836)
1. On sample size calculation for comparing survival curves under general hypothesis testing.
Jung SH; Chow SC
J Biopharm Stat; 2012; 22(3):485-95. PubMed ID: 22416836
[TBL] [Abstract][Full Text] [Related]
2. A unified approach to power and sample size determination for log-rank tests under proportional and nonproportional hazards.
Tang Y
Stat Methods Med Res; 2021 May; 30(5):1211-1234. PubMed ID: 33819109
[TBL] [Abstract][Full Text] [Related]
3. A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.
Xiong X; Wu J
Pharm Stat; 2017 Jan; 16(1):87-94. PubMed ID: 27860138
[TBL] [Abstract][Full Text] [Related]
4. Sample size calculation for the proportional hazards cure model.
Wang S; Zhang J; Lu W
Stat Med; 2012 Dec; 31(29):3959-71. PubMed ID: 22786805
[TBL] [Abstract][Full Text] [Related]
5. Sample size calculation for testing differences between cure rates with the optimal log-rank test.
Wu J
J Biopharm Stat; 2017; 27(1):124-134. PubMed ID: 26882262
[TBL] [Abstract][Full Text] [Related]
6. Sample size calculation for the weighted rank statistics with paired survival data.
Jung SH
Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
[TBL] [Abstract][Full Text] [Related]
7. Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards.
Yung G; Liu Y
Biometrics; 2020 Sep; 76(3):939-950. PubMed ID: 31797363
[TBL] [Abstract][Full Text] [Related]
8. Are restricted mean survival time methods especially useful for noninferiority trials?
Freidlin B; Hu C; Korn EL
Clin Trials; 2021 Apr; 18(2):188-196. PubMed ID: 33626896
[TBL] [Abstract][Full Text] [Related]
9. Power and sample size calculation for log-rank test with a time lag in treatment effect.
Zhang D; Quan H
Stat Med; 2009 Feb; 28(5):864-79. PubMed ID: 19152230
[TBL] [Abstract][Full Text] [Related]
10. Subgroup detection and sample size calculation with proportional hazards regression for survival data.
Kang S; Lu W; Song R
Stat Med; 2017 Dec; 36(29):4646-4659. PubMed ID: 28791726
[TBL] [Abstract][Full Text] [Related]
11. A win ratio approach for comparing crossing survival curves in clinical trials.
Zheng S; Wang D; Qiu J; Chen T; Gamalo M
J Biopharm Stat; 2023 Jul; 33(4):488-501. PubMed ID: 36749067
[TBL] [Abstract][Full Text] [Related]
12. Sample size determination for comparing several survival curves with unequal allocations.
Halabi S; Singh B
Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
[TBL] [Abstract][Full Text] [Related]
13. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
Horiguchi M; Hassett MJ; Uno H
Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
[TBL] [Abstract][Full Text] [Related]
14. Sample size determination for comparing more than two survival distributions.
Ahnn S; Anderson SJ
Stat Med; 1995 Oct; 14(20):2273-82. PubMed ID: 8552903
[TBL] [Abstract][Full Text] [Related]
15. Sample size computation for two-sample noninferiority log-rank test.
Jung SH; Kang SJ; McCall LM; Blumenstein B
J Biopharm Stat; 2005; 15(6):969-79. PubMed ID: 16279355
[TBL] [Abstract][Full Text] [Related]
16. Single-Arm Phase II Survival Trial Design Under the Proportional Hazards Model.
Wu J
Stat Biopharm Res; 2017; 9(1):25-34. PubMed ID: 28966721
[TBL] [Abstract][Full Text] [Related]
17. A sample size formula for the supremum log-rank statistic.
Eng KH; Kosorok MR
Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
[TBL] [Abstract][Full Text] [Related]
18. Sample size calculation for studies with grouped survival data.
Li Z; Wang X; Wu Y; Owzar K
Stat Med; 2018 Nov; 37(27):3904-3917. PubMed ID: 29888484
[TBL] [Abstract][Full Text] [Related]
19. Sample size calculation for the one-sample log-rank test.
Wu J
Pharm Stat; 2015; 14(1):26-33. PubMed ID: 25339496
[TBL] [Abstract][Full Text] [Related]
20. Weighted log-rank test for time-to-event data in immunotherapy trials with random delayed treatment effect and cure rate.
Liu S; Chu C; Rong A
Pharm Stat; 2018 Sep; 17(5):541-554. PubMed ID: 30058101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
